- Home
- ARVN vs MUX Comparison
ARVN vs MUX Comparison
Compare ARVN & MUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- MUX
- Stock Information
- Founded
- ARVN 2015
- MUX 1979
- Country
- ARVN United States
- MUX Canada
- Employees
- ARVN N/A
- MUX N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- MUX Precious Metals
- Sector
- ARVN Health Care
- MUX Basic Materials
- Exchange
- ARVN Nasdaq
- MUX Nasdaq
- Market Cap
- ARVN 438.1M
- MUX 423.9M
- IPO Year
- ARVN 2018
- MUX N/A
- Fundamental
- Price
- ARVN $8.98
- MUX $7.82
- Analyst Decision
- ARVN Buy
- MUX Strong Buy
- Analyst Count
- ARVN 15
- MUX 2
- Target Price
- ARVN $31.86
- MUX $15.25
- AVG Volume (30 Days)
- ARVN 2.8M
- MUX 781.2K
- Earning Date
- ARVN 05-06-2025
- MUX 05-07-2025
- Dividend Yield
- ARVN N/A
- MUX N/A
- EPS Growth
- ARVN N/A
- MUX N/A
- EPS
- ARVN N/A
- MUX N/A
- Revenue
- ARVN $263,399,999.00
- MUX $174,477,000.00
- Revenue This Year
- ARVN N/A
- MUX $29.49
- Revenue Next Year
- ARVN N/A
- MUX N/A
- P/E Ratio
- ARVN N/A
- MUX N/A
- Revenue Growth
- ARVN 235.54
- MUX 4.96
- 52 Week Low
- ARVN $5.94
- MUX $6.38
- 52 Week High
- ARVN $37.38
- MUX $12.50
- Technical
- Relative Strength Index (RSI)
- ARVN 52.04
- MUX 49.32
- Support Level
- ARVN $5.94
- MUX $6.38
- Resistance Level
- ARVN $6.86
- MUX $8.42
- Average True Range (ATR)
- ARVN 0.55
- MUX 0.45
- MACD
- ARVN 0.58
- MUX 0.03
- Stochastic Oscillator
- ARVN 93.47
- MUX 56.25
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About MUX McEwen Mining Inc.
McEwen Mining Inc is a mining and minerals production and exploration company that focuses on precious and base minerals in Argentina, Mexico, and the United States. The company primarily generates its revenue from gold and silver production. It owns and operates the wholly-owned El Gallo 1 mine in Mexico and holds a minority stake in the company that manages the San Jose mine in Argentina. More than half of the company's gold output comes from the El Gallo 1 mine, while the remaining gold production and the majority of silver production are sourced from the San Jose mine. Geographically, most production occurs in the United States.